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Abstract
Introduction—Stem cell-based therapies represent a valid approach to restore cardiac function 
due to their beneficial effect in reducing scar area formation and promoting angiogenesis. 
However, their translation into the clinic is limited by the poor differentiation and inability to 
secrete sufficient therapeutic factors. To address this issue, several strategies such as genetic 
modification and biophysical preconditioning have been used to enhance the efficacy of stem cells 
for cardiac tissue repair.
Methods—In this study, a biomimetic approach was used to mimic the natural mechanical 
stimulation of the myocardium tissue. Specifically, human adipose-derived stem cells (hASCs) 
were cultured on a thin gelatin methacrylamide (GelMA) hydrogel disc and placed on top of a 
beating cardiomyocyte layer. qPCR studies and metatranscriptomic analysis of hASCs gene 
expression were investigated to confirm the correlation between mechanical stimuli and 
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cardiomyogenic differentiation. In vivo intramyocardial delivery of pre-conditioned hASCs was 
carried out to evaluate their efficacy to restore cardiac function in mice hearts post-myocardial 
infarction.
Results—The cyclic strain generated by cardiomyocytes significantly upregulated the expression 
of both mechanotransduction and cardiomyogenic genes in hASCs as compared to the static 
control group. The inherent angiogenic secretion profile of hASCs was not hindered by the 
mechanical stimulation provided by the designed biomimetic system. Finally, in vivo analysis 
confirmed the regenerative potential of the pre-conditioned hASCs by displaying a significant 
improvement in cardiac function and enhanced angiogenesis in the peri-infarct region.
Conclusion—Overall, these findings indicate that cyclic strain provided by the designed 
biomimetic system is an essential stimulant for hASCs cardiomyogenic differentiation, and 
therefore can be a potential solution to improve stem-cell based efficacy for cardiovascular repair.
Keywords
Mechanical stimulation; Myogenic differentiation; Angiogenesis; Cardiac repair
INTRODUCTION
Myocardial infarction is one of the leading causes of mortality affecting people all over the 
world.16,76 This pathology occurs when there is a reduction of blood flow to the myocardial 
tissue caused by a partial or complete blockage of a coronary artery due to the formation of a 
cholesterol plaque.14 Traditional cardiac treatments such as stents, bypass surgery, and valve 
replacement aim to restore normal blood flow to the ischemic area but do not address the 
underlying cause of the disease.60 For this reason, there is an urgent need for alternative 
strategies that can boost the limited regenerative capacity of the myocardial tissue and 
reduce the risk of disease reoccurrence.
To this end, stem cell-based therapies represent a possible solution to overcome the 
limitations of current treatments aimed to promote myocardium regeneration. Among the 
variety of stem cell types, adult stem cells represent the ideal choice because they overcome 
ethical issues associated with the use of embryonic stem cells and possess a limited risk of 
immune rejection when harvested from the same patient. Additionally, they display other 
advantages including ease of harvest from different tissue sources (adipose, bone marrow, 
and umbilical cord, etc.), the possibility of in vitro expansion, and secretion of beneficial 
paracrine factors.20,60,62
Despite the aforementioned features and the efficacy demonstrated in pre-clinical studies, 
stem cell-based therapies present a limited translation into the clinic. One of the major 
reasons is that stem cells have a limited ability to function as competent myocytes and show 
poor differentiation and engraftment within the host tissue upon delivery to the myocardium. 
These limitations impact their survival rate and the long-term regenerative potential in vivo.
60,62
Several in vitro approaches have been investigated to resolve these issues by augmenting the 
survival rate or the differentiation of adult stem cells before their transplantation. One 
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possibility is to promote cardiomyogenic differentiation of stem cells prior to their delivery 
by genetic modification. For instance, expression of pro-survival markers such as 
protooncogene serine/threonine-protein kinase (Pim-1), B cell lymphoma-2 (Bcl2), 
Glycogen synthase kinase 3-beta (Gsk3-β) and GATA binding protein 4 (GATA4) have been 
shown to enhance stem cells proliferation and survival rate at the injured myocardium.
7,13,32,33 Similarly, other studies have focused their attention on introducing insulin-like 
growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), and angiopoietin-1 
(Ang1) genes in the genome of stem cells to induce cardiac differentiation and angiogenesis.
52,55,59,61 Gene transfection can be carried out by using both viral and non-viral carriers, 
however, several issues such as safety concerns, limited transfection efficiency and potential 
gene silencing in the host cell hinder the clinical translation of this strategy.73 Aside from 
gene delivery and genome editing, stem cells can be treated with growth factors such as 
TGF-β1, IGF-1, and FGF or small molecules and drugs including 5-azacytidine, ascorbic 
acid, retinoic acid and dynorphin B.19,25 In addition, adult stem cells can be co-cultured with 
neonatal rat cardiomyocytes in vitro. The direct cell-to-cell contact between the two different 
cell lines has been shown to induce a change in the stem cell phenotype in adult stem cells 
towards a cardiomyogenic lineage due to more efficient transduction of molecular signals.
19,77 Moreover, other pre-conditioning treatments involve the culture of stem cell in hypoxic 
condition and serum starvation, which has been shown to increase their proliferation and 
differentiation due to upregulation of pro-survival and pro-angiogenic signaling pathways.
21,57 Although promising, the mentioned pre-conditioned systems present a limited 
protective response due to down-regulation or desensitization of stem cell surface receptors.
39 Another drawback is that all of the methods described above fail to consider the 
physiological environment of the myocardial tissue, which is a complex milieu of both 
biochemical and physical signals that dictate stem cell proliferation and differentiation.
A more efficient approach, which can closely mimic the intricate dynamics occurring in the 
native myocardium, considers the physical stimuli produced by the constant beating of 
cardiomyocytes as a cue to promote stem cell myogenic differentiation. Stem cells can sense 
these mechanical stimuli through a diverse group of membrane-anchored receptors such as 
stretch-activated ion channels, integrins and G-protein coupled receptors (GPCRs). The 
stimulation of these receptors leads to the activation of a multi-step signaling cascade, which 
can, in turn, upregulate selective transcription factors responsible for stem cell myogenic 
differentiation.9 Possible ways to recreate the mechanical environment of the beating heart 
consist of using bioreactors that emulate the cyclic strain produced by cardiomyocytes. 
Specifically, efforts in this direction have demonstrated a direct correlation between the 
application of a cyclic strain and cardiomyogenic differentiation of embryonic stem cells.
17,22
Based on this concept, we aimed to develop a biomimetic system that can induce 
cardiomyogenic differentiation of stem cell upon exposure to cyclic strain generated by 
beating cardiomyocytes. Human adipose-derived stem cells (hASCs) were selected as the 
model stem cell line due to the ease of harvesting along with their inherent pro-angiogenic 
properties.8 hASCs were cultured on thin discs made of gelatin methacrylamide (GelMA), 
which were then placed on top of a monolayer of beating cardiomyocytes. GelMA is a well-
known derivate of gelatin that has displayed excellent biocompatibility and can be processed 
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into photocrosslinkable discs with tunable mechanical properties.27 The inclusion of the thin 
polymeric disc allowed the transmission of the mechanical stimuli to the hASCs monolayer 
that could be easily harvested at the end of the treatment. Furthermore, we tested the 
influence of cyclic strain on the genetic and angiogenic growth factor secretion profile of 
hASCs exposed to the physical stimuli in comparison to a static culture control. Finally, we 
delivered the pre-conditioned hASCs in an acute myocardial infarction (AMI) mice model 
and tested their ability to restore heart function by assessing ejection fraction, fractional 
shortening, scar area reduction and neovascularization in the periinfarct region.
MATERIALS AND METHODS
Gelatin Methacrylamide Synthesis
Gelatin methacrylamide (GelMA) was synthesized following a previously established 
protocol.71 Briefly, gelatin A (300 bloom grade, from porcine skin, Sigma-Aldrich, USA) 
was dissolved in phosphate buffered saline (PBS, 100 mL) at the concentration of 10% w/v 
while maintaining the temperature at 50 °C. 0.8 mL of methacrylic anhydride (Sigma-
Aldrich, USA) per gram of gelatin was added dropwise, and the reaction mixture was stirred 
for 2 h at 50 °C. After the reaction was completed, the polymeric mixture was diluted with 
PBS (100 mL). Next, the undesired byproducts such as methacrylic acid were removed by 
dialyzing the solution (12–14 kDa molecular weight cut off) against distilled water for 7 
days at 40 °C. The solution was then vacuum filtered (0.22 μm pore size), frozen in − 80 °C 
and lyophilized for 7 days. Finally, the freeze-dried polymer was used to fabricate GelMA 
discs.75
GelMA Disc Fabrication
GelMA discs hydrogels were obtained by solubilizing GelMA in PBS at the concentration of 
7% w/v. The photoinitiator Irgacure 2959 (Sigma-Aldrich, USA) was mixed in the 
polymeric solution at the concentration of 0.1% w/w before UV irradiation. 
Photocrosslinked hydrogel discs were obtained by adding 150 μL of the polymer solution on 
a petri dish between two 100 μm thick spacers. A glass slide was gently placed on top of this 
pre-polymeric solution and exposed to UV irradiation (Omnicure S200, Lumen Dynamics, 
Canada) for 80 s at an intensity of 7 mW/cm2. The photo-crosslinked GelMA discs (100 μm 
thick) were then rinsed with PBS to remove any uncrosslinked polymer and treated with 1% 
penicillin/ streptomycin (P/S) before using them for cell culture experiments.44
Frequency Sweep Analysis of GelMA Discs
The viscoelastic properties of the GelMA discs were studied by running a frequency sweep 
in the range of 0.01–10 Hz at 37 °C and 1% of strain using the AR 2000 Rheometer (TA 
Instruments, New Castle, DE). To define the range of viscoelastic region, preliminary strain 
sweep tests were carried out in the range of 0.1–100% of strain at the frequency of 1 Hz. The 
hydrogel discs (100 μm height, n = 3) were tested using a 20 mm smooth steel plate 
geometry, and frequency sweeps were performed on the swollen hydrogels discs. 
Specifically, GelMA discs were analyzed after soaking them for 1 h and 7 days in PBS 0.1 
mM (pH 7.4), respectively. We also performed frequency sweep analysis on GelMA discs 
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seeded with hASCs for 7 days to study whether the presence of hASCs had any effect on the 
mechanical properties of the GelMA discs.44
Swelling Study
Swelling studies were performed on freeze-dried hydrogel discs by first weighing them in 
the dried state and then soaking the gels in PBS at 37 °C. The swollen hydrogels were 
weighed at defined time intervals to assess the equilibrium of swelling. The swelling ratio 
(%) was measured using the following formula:




where Ws is the weight of the swollen hydrogel, and Wd represents the weight of the freeze-
dried hydrogel.44,45
Human Adipose-Derived Stem Cells (hASCs) Culture
hASCs (Lot number 00061, donor: female 31–45 years old) were procured from RoosterBio 
(USA) and maintained in alpha-minimum essential medium (α-MEM, Invitrogen, USA) 
with 15% v/v fetal bovine serum (FBS) and 1% v/v penicillin-streptomycin (P/S) at 37 °C 
and 5% CO2. Passages 3–5 were used for all the studies. hASCs were seeded in 2D on the 
hydrogel discs at a cell density of 5 × 104 cells/mL and grown until 80% of confluency for 2 
days.
Cardiomyocytes (CMs) Cell Culture
iPSC- derived human CMs (Lot number 103321) were purchased from cellular dynamics 
(Madison, WI, USA) and grown according to the manufacturer’s protocol. Briefly, 24 well 
plates were coated with a 0.1% w/v gelatin solution for 1 h, which was removed before 
adding the cell suspension. CMs were seeded on the treated well plates at a concentration of 
1.2 × 105 cells/cm2 using the provided plating media. Cells were cultured at 37 °C and in a 
7% CO2 environment. 48 h post-seeding, the plating media was replaced with an appropriate 
volume of maintenance media. Mechanically active cardiomyocytes were ready to be used 2 
weeks post-culture. At this time point, cells formed a uniform monolayer with a 
synchronous beating.
Design of the Biomimetic Co-Culture System
The co-culture system was set up by first replacing the maintenance media for CMs with α-
MEM media (15% FBS, 1% P/S). Next, the GelMA discs with hASCs seeded on them were 
gently placed onto the wells seeded with CMs without disturbing the cell layer.
Additionally, hASCs were cultured in a transwell, which was placed in the well containing 
CMs to study the effect of cardiomyogenic differentiation induced by the secretion of 
paracrine molecules. Both co-culture setups were maintained in α-MEM media (15% FBS, 
1% P/S) at 37 °C and 7% CO2 for the entire duration of the experiments.
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Immunofluorescence images of the co-culture were obtained by laser scanning confocal 
microscopy (LSCM). CMs were cultured on a 24-well glass-bottom tissue culture plate 
(IBDI, Germany) and hASCs were seeded on the GelMA discs as mentioned previously. 
Each cell monolayer was stained separately to visualize the distinct cell populations. 
Specifically, CMs were stained with phalloidin-AlexaFluor488 (Invitrogen, USA) to 
visualize actin fibers, while the actin component of hASCs’ cytoskeleton were stained with 
phalloidin-AlexaFluor594 (Invitrogen, USA). In both cases, the nuclei were stained with 
DAPI (Sigma-Aldrich, USA). All images were processed using the ImageJ software.
Immunoflourescence
To study the translocation of YAP1 and TAZ into the nucleus, we performed 
immunostaining of the hASCs seeded on GelMA discs. The hydrogel discs were retrieved 
after 7 days of co-culture (cyclic strain) and fixed with 4% paraformaldehyde. The cells 
were permeabilized with 0.3% Triton X-100 and blocked with 5% normal goat serum (45 
min) following which they were stained with Purified Mouse anti-TAZ (BD Biosciences, 
USA) and anti-YAP1 (Abnova, Taiwan) monoclonal antibodies according to manufacturer’s 
protocols. Samples were then counterstained with Goat anti-mouse AlexaFluor 594 
(Invitrogen, USA), which served as the fluorescent-labelled secondary antibody. Lastly, 
Diamidino-2-phenylindole dilactate (DAPI, Sigma-Aldrich, USA) was added to visualize the 
nuclei and images were obtained using fluorescent microscopy at 40× magnification.15
Beating Frequency Measurements
The following protocol was adopted to measure the beating frequency of CMs and 
corresponding displacement of hASCs layer on the GelMA discs. A suitable reference image 
of cells was taken at time t0 when the average motility is minimal. This image depicts a 
contraction-free state. The reference image was then compared to all the other images using 
particle image velocimetry (PIV) analysis. For each time point t and location x, the total 
movement (magnitude and directionality) relative to the reference image was calculated to 
obtain a series of displacement vector fields d(t,x). The average displacement (beat pattern) 
D(t) was measured at each time point t as the spatial average of the magnitudes|d(t,x)| for 
each displacement vector field. The D(t) displacement curves show a series of single peaks, 
which rise and decrease similar to an exponential function.56
qPCR Analysis of Mechanotransduction and Myogenic Differentiation Markers
Two different groups were investigated for qPCR analysis: (i) static control group (hASCs 
seeded on GelMA discs without exposure to cyclic strain of beating CMs) (ii) cyclic strain 
group (hASCs seeded on GelMA discs, co-cultured with beating cardiomyocytes). qPCR 
analysis of hASCs expression profile was carried out on Day 1 and Day 7 of treatment n = 
3). Mrna from each group was extracted at different time points using an RNeasy Mini Kit 
(Qiagen, Germany) and measured using a NanoDrop (Thermo Scientific, USA). Next, 
mRNA was converted to cDNA using the High-Capacity cDNA Conversion Kit (Applied 
Biosystems, USA). Finally, gene expression was evaluated using a mixture of predesigned 
primers and the KiCqStart SYBR Green Master Mix (Sigma-Aldrich, USA). All qPCR 
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reactions were carried out with a Mastercycler Realplex (Eppendorf, Germany) and the fold 
expression levels were calculated using the relative ΔΔCt method. GAPDH was employed as 
the housekeeping gene. Specifically, the effect of CMs beating over hASCs 
mechanotransduction response was studied by measuring the upregulation of ACTA2, TAZ, 
CDC42 and YAP1 markers. Myogenic differentiation was evaluated by assessing the 
expression of ACTC1 and TNNT2 genes.
Finally, to study the effect of cardiomyogenic differentiation induced by the secretion of 
paracrine molecules in the co-culture system, an additional group was investigated 
consisting of hASCs cultured on a transwell placed in a well seeded with CMs. The 
expression of ACTC1 and TNNT2 genes was assessed at 7 days and compared to the cyclic 
strain group.
RNA Extraction and cDNA Library Preparation
mRNA from each group was extracted at different time points using an RNeasy Mini Kit 
(Qiagen, Germany) and the quality of mRNA was measured using a 4200 TapeStation 
System (Agilent Technologies, Palo Alto, CA). The Metatranscriptome libraries were 
generated using TruSeq Stranded mRNA sample preparation kit (Illumina) on the Biomek 
FXP device following the manufacturer’s protocol. This automation method generates high 
quality stranded mRNA sequencing libraries compatible with Illumina sequencers. The 
enriched mRNA from the samples were polyadenylated using Escherichia coli poly(A) 
polymerase and converted to double-stranded complementary DNA (cDNA) via reverse 
transcription. The double-stranded cDNA from all samples were digested, purified and 
pooled together. The resulting library was quantified by qPCR and sequenced by Illumina 
MiSeq instrument using V3 reagents (Roche, Indianapolis, IN).
Metatranscriptomics Data Analysis
The quality of the sequence reads was verified with a FastQC software, which is a quality 
control tool for high throughput data (http://www.bioinformatics.babraham.ac.uk). Tophat 
(version 2.1.1) and Cufflinks (version 2.2.1) programs were used with default parameters to 
assemble de-novo transcriptomes.65 To understand the differential gene expression between 
the static control and cyclic strain groups, the relative expression of transcriptome was 
generated based on the Fragments Per Kilobase of transcript per Million mapped read 
(FPKM) in Cufflinks. The resulting FPKM values and fold change were visualized in the 
generated heatmaps using ggplot2, an open source R package (http://www.r-project.org/).72
Secretome Analysis
The conditioned media (secretome) was collected from static and cyclic strain groups at 7 
days posttreatment, and an angiogenesis array was performed to detect the relative 
expression of several angiogenic growth factors (n = 3). A human angiogenesis array 
(RayBiotech) was used for this purpose according to the manufacturer’s protocol. The 
signals were visualized using a laser scanner equipped with a Cy3 wavelength (Axon 
GenePix).
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In Vivo Acute Myocardial Infarction Surgery
Animal studies were performed according to the NIH Guide Care and Use of Laboratory 
Animals protocols (NIH publication 85–23, revised 1985) approved by the Institutional 
Animal Care and Use Committee (IACUC). In vivo experiments were carried out using an 
acute myocardial infarction (AMI) mice model consisting of 12-week-old female C57BL/6 
mice. Cyclosporine (Sigma, 20 mg/kg body weight/day) was delivered through 
intraperitoneal injection. The drug was administered 2 days before the surgery and was 
injected for the entire duration of the experiment (21 days). Briefly, animals were 
anaesthetized with isoflurane gas, tracheally intubated and maintained on a Rodent ventilator 
(Minivent, Type 845 Germany) to assist their respiratory function. The body temperature of 
the mice was maintained at 37 °C for the duration of the surgery. The mice hearts were 
exposed by minimal left-sided thoracotomy, and myocardial infarction was induced by 
occlusion of the left anterior descending coronary artery following previously established 
protocols.47,50 Fifteen minutes post ligations of the arteries, the mice with AMI were 
subjected to different treatments (n = 4). Specifically, either PBS (sham control), Matrigel® 
(vehicle control), hASCs cultured in static conditions (hASC static) or hASCs pre-
conditioned using the designed in vitro biomimetic system (hASC cyclic) were injected into 
the peri-infarct region of mice hearts 15 min post-infarction. hASCs for the last two groups 
were pre-cultured on the GelMA discs for 7 days and harvested using trypsin for 5 min and 
ultimately encapsulated in a Matrigel® hydrogel before injection into the injured 
myocardium. 5 × 104 cells/heart were delivered using 100 μL of Matrigel®, which was 
injected intramyocardially at multiple sites (3 sites/heart). Cardiac function was assessed by 
performing transthoracic echocardiography at day 3, and day 21 post surgery. At day 21, all 
animals were sacrificed. The excised hearts were either frozen or fixed with a 4% formalin 
solution for further studies.
In Vivo Assessment of Cardiac Function
Cardiac function was evaluated by carrying out transthoracic echocardiography at day 3, and 
day 21 post surgery using the Vevo®2100 Imaging System Visualsonics following a 
previously established procedure.51 After the mice were anesthetized using isoflurane gas, 
2D images of hearts were obtained for M-modes through the anterior and posterior left 
ventricle (LV) walls. Indices of left ventricle (LV) systolic function including LV ejection 
fraction (EF), LV fractional shortening (FS), cardiac output (CO), and stroke volume (SV) 
were calculated using the following formulae2,47,51:
EF (%) = (LVEDd)3 − (LVESd)3/(LVEDd)3 × 100 (2)
FS = [LVEDd − LVESd / LVEDd] × 100 (3)
Cardiac output = heart rate × stroke volume, (4)
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SV = EDV − ESV (5)
where, LVEDd corresponds to the end-diastolic diameter of the left ventricle and LVESd is 
the endsystolic diameter of the left ventricle measured from three consecutive cardiac cycles. 
EDV is the end-diastolic volume and ESV corresponds to the end-systolic volume.
Immunostaining of Heart Sections
Paraffin-embedded heart sections were deparaffinized by soaking the tissue sections 
alternatively in xylene and ethanol solutions (100%) for 5 mins each. Antigen retrieval was 
then performed using a citrate buffer solution and samples were then blocked using a CAS-
block Histochemical Reagent (Thermo Fischer Scientific, USA) at room temperature for 2 h. 
This process was followed by three consecutive washes with PBS (5 min each). Samples 
were then incubated overnight at 4 °C with primary antibodies for von Willebrand Factor 
(vWF) (catalog # A0082, Dako, Agilent Pathology Solutions, USA) and smooth muscle 
actin (SMA) (catalog # A2547 SIGMA, Sigma-Aldrich, USA).52,53 Primary antibodies were 
used at a working dilution of 1:200 with CAS-Block. After washing samples with PBS three 
times (5 min each), they were incubated with the corresponding secondary antibodies 
(working dilution of 1:200 with CAS-Block) for 2 h at room temperature. DAPI (Sigma-
Aldrich, USA) staining was performed to stain nuclei and images were obtained using 
fluorescent microscopy.18
Statistical Analysis
qPCR analysis, infarct size area, blood vessels density, CO, EF, FS and stroke volumes were 
assessed using four animals for each treatment group. Results were expressed as mean ± 
standard deviation. The differences among the groups were calculated using student’s t test 
and one-way ANOVA for repeated measurements with Tukey post hoc comparisons. 
Statistical significance for all tests should be p < 0.05 (GraphPad Prism Software). (*p < 
0.05, **p < 0.01, and ***p < 0.001).
RESULTS AND DISCUSSION
Design and Characterization of the Biomimetic Co-Culture System
Current cardiovascular treatments based on stem cell therapies suffer a series of limitations 
including lack of cell engraftment and limited differentiation at the injured site.20,60 These 
drawbacks are mainly due to a limited control over stem cell fate upon in vivo 
administration into the myocardial tissue. Therefore, there is a need to develop in vitro 
strategies aimed to modulate stem cells’ genetic profile as a preliminary step to increase 
their differentiation capabilities. Based on this concept, we have designed a strategy that can 
help achieve this goal without any drug treatment or genetic manipulation.
The proposed in vitro biomimetic approach provides a mechanical stimulus as a guiding 
factor to promote cardiomyogenic differentiation of stem cells. hASCs were seeded on a 
GelMA hydrogel disc, which was placed on top of a beating cardiomyocytes layer cultured 
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on a well plate (Fig. 1a). GelMA was used in this study due to its biocompatibility and ease 
of fabrication into thin layers (100 μm) using UV crosslinking.67,75 The hydrogel can be 
washed after the network formation to remove unreacted photoreagents and can be 
customized in different sizes simply by varying the volume of polymer used before the 
process of crosslinking. The inclusion of a thin polymeric disc separating the two cell layers 
allows for easy harvesting of the hASCs from the GelMA disc after being exposed to the 
physical stimuli.
Confocal analysis was used to display the presence of the different cell layers in the 
biomimetic system (Fig. 1b, Video S1). The x and y axis were kept constant while changing 
the z coordinate during the imaging process. All the individual layers were stacked together 
to obtain a 3D image of the construct. The bottom layer is represented by CMs stained with 
Alexa Fluor 498 phalloidin to visualize actin fibers. Additionally, the top layer is formed by 
hASCs seeded on the hydrogel disc stained with Alexa Fluor 594 phalloidin to investigate 
actin organization. hASCs spread and displayed a spindle-like morphology on the surface of 
the hydrogel forming a confluent monolayer after 2 days post-seeding.
Previous studies have relied on the use of artificial bioreactors to simulate the cardiomyocyte 
beating, however these approaches present a limited ability to recreate the physiological 
heart function.17,22,58 On the contrary, our approach can better mimic the mechanical 
environment of the myocardial tissue since CMs are used to produce the mechanical 
stimulus.
The addition of a GelMA disc on the CMs did not affect their beating ability through the 7 
days of the study (Video S2). CMs beating profile has been characterized by PIV analysis 
using image J. The beating generated by CMs was able to produce a corresponding 
displacement in the hASCs layer cultured on the hydrogel (Video S3). The average 
displacement D(t) produced on the hASCs monolayer on the GelMA disc was constant as 
reported (Fig. 1c). However, the two displacement graphs were not in sync with each other 
probably due to a time delay in the translation of the mechanical force from the bottom to 
the top layer.
The hydrogel could be removed after 7 days of culture while still maintaining its mechanical 
integrity as demonstrated by rheological studies. For instance, GelMA discs displayed 
similar G’ values at day 1 and day 7 as measured in the frequency sweep test after 7 days of 
contact in phosphate buffer saline (PBS, pH 7.4) (Fig. 1d). Similarly, GelMA discs seeded 
with hASCs and cultured for 7 days displayed the same value of G’ (Fig. S1). G’ or storage 
modulus is indicative of the degree of crosslinking of the GelMA network, and no 
significant change was observed in the range of frequencies tested. Freeze-dried GelMA 
discs were able to swell when in contact with PBS buffer and they reached an equilibrium of 
swelling after 4 days (Fig. 1e). Overall, these findings suggest that the proposed approach 
can successfully expose hASCs to a constant cyclic strain, which can be obtained without 
the use of any external mechanical device.
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Effect of Cardiomyocytes Beating on hASCs Genetic Profile and Growth Factor Expression
The myocardial tissue is a mechanically dynamic environment where cardiomyocytes 
generate a constant cyclic strain determined by their rhythmic beating. Several studies have 
demonstrated the direct relation between this mechanical signal and the biological influence 
over stem cells fate.17,22 Based on this concept, the second part of the study was focused on 
defining whether mechanical stimulation generated by the beating of CMs could promote 
hASCs activation of mechano-transduction genes and the corresponding differentiation 
towards a cardiomyogenic lineage without the use of any external biochemical factors.
As the first step, we have determined the expression of several key genes that regulate the 
ability of hASCs to sense mechanical signals provided in the form of CMs beating. These 
genes are involved in an array of signaling cascades that allow the translation of a 
mechanical stimulus into a biological response.9 hASCs were exposed to CMs beating 
(cyclic strain) for 24 h, and the expression of Yes-associated protein 1 (YAP1), Tafazzin 
(TAZ), Cell division cycle-42 (CDC42) and alphα-actin-2 (ACTA2) was investigated. qPCR 
results were compared to the genetic expression of hASCs seeded on GelMA disc without 
any mechanical treatment (Static Control). A higher expression of the aforementioned 
mechano-transduction markers was observed within 24 h in hASCs subjected to cyclic strain 
when compared to the static control group (Fig. 2a).
Specifically, YAP1 and TAZ genes encode for the corresponding proteins which are 
transcription coactivators of the Hippo pathway that controls cell growth, proliferation, and 
cell differentiation. The presence of a mechanical stimulus can induce the activation of both 
YAP1 and TAZ that are translocated into the nuclei and associate with the transcription 
enhancer factor 1 (TEF-1) also known as TEAD (Fig. 2b). Consequently, this binding step 
activates the transcription of other genes that can regulate stem cell differentiation into 
several lineages such as bone, adipose and cardiac tissue.6,11,34,38,46 We have proved the 
nuclear translocation of the YAP1-TAZ complex in the nucleus of hASCs by 
immunofluorescence staining after 7 days of co-culture using the designed biomimetic 
system (Fig. S2). Aside from the upregulation of YAP1 and TAZ genes, we observed the 
overexpression of two others key genes such as ACTA2 and CDC42 that are involved in the 
α-actin formation and actin polymerization respectively. The observed increase in CDC42 
expression can be explained by the involvement of CDC42 protein as a regulator in the 
YAP1-TAZ mechano-transduction pathway as similarly reported in another study.34 These 
results indicate that the cardiomyocytes cyclic strain provided a sufficient mechanical 
stimulus capable of modulating the mechanobiological response in hASCs.
Subsequently, it was important to verify whether the biological modulation induced by CMs 
beating was responsible for modifying the genetic profile of hASCs towards a 
cardiomyogenic lineage. Particularly, recent studies have investigated the effect of cyclic 
strain on another type of stem cell as one of the possible factors directing their 
differentiation into cardiomyocytes.17,22 Hence, we focused our investigation on the 
expression of myogenic differentiation markers in hASCs posttreatment with cyclic strain.
qPCR analysis revealed a higher expression of alpha-cardiac actin (ACTC1) 5.12 ± 1.43 and 
Troponin T2 (TNNT2) 1.58 ± 0.30 in the cyclic strain group after 7 days of exposure in 
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comparison with the static group (Fig. S3). ACTC1 encodes for α-actin, which is one the 
main protein forming the contractile apparatus of cardiac sarcomeres.3 Similarly, TNNT2 
regulates the expression of cardiac troponin T2, which is located in the thin filament of the 
striated muscles and plays a major role in cardiac muscle contraction.64
Additionally, we performed a metatranscriptomic analysis of the main angiogenic and 
myogenic differentiation markers between the two groups. The generated heat maps indicate 
a higher fold change in the expression levels of key angiogenic and myogenic markers in the 
cyclic strain group (Fig. 2c). The list of the genes and their functions have been provided in 
Table 1. This data confirms the successful modulation of the genetic profile of hASCs 
towards a cardiomyocyte-like lineage. Hence, the cyclic strain provided by our designed 
biomimetic system is an efficient stimulant for cardiomyogenic differentiation of hASCs 
without the need of any additional biological factors.
Another important aspect to consider while designing a therapeutic stem cell-based strategy 
for cardiovascular regeneration is the need for a pro-angiogenic paracrine response that 
controls stem cell survival and cardiac remodeling. For instance, hASCs inherently possess 
the ability to secrete angiogenic growth factors such as Angiogenin, VEGF, bFGF, and HGF. 
These proteins can be beneficial for myocardial protection, cardiomyocytes proliferation and 
progenitor stem cell recruitment.35–37,48,78 For this reason, it was essential to verify whether 
the secretion profile of hASCs (secretome) was affected by the mechanical stimulation 
produced by the designed biomimetic system.
To assess this important factor, we performed an angiogenesis array on the secretome 
obtained from the static and the cyclic strain groups after 7 days of culture (Fig. S4). 
Angiogenin and VEGF were the most abundantly expressed growth factors but no 
significant difference in their concentration was found between the two groups. On the 
contrary, the secretion profile of HGF, Leptin, and PIGF was slightly increased in the cyclic 
strain group suggesting a possible effect of cyclic strain in enhancing the pro-angiogenic 
potential of hASCs. Overall, these findings indicate that the mechanical stimulation provided 
did not hamper hASCs’ ability to secrete a therapeutic secretome. Aside from their 
beneficial angiogenic properties, these paracrine factors can also regulate myogenic 
differentiation of mesenchymal stem cells as demonstrated in other studies.1,4,49,74 
Therefore, we selected a co-culture setup where hASCs were exposed to cardiomyocytes 
paracrine factors without receiving any mechanical stimulation. Briefly, hASCs were 
cultured in a transwell and placed in co-culture with CMs without being exposed to CM 
beating (cyclic strain (−)) (Figure S5A). This additional study was important to demonstrate 
whether the co-culture secretome played a role in the upregulation of the cardiomyogenic 
markers observed in our study. qPCR analysis of ACTC1 and TNNT2 after 7 days of co-
culture displayed no significant increase in both genes when compared to our biomimetic 
strategy (cyclic strain (+)) where hASCs were subjected to CM beating (Fig. S5B). Thus, the 
mechanical stimulation provided by our biomimetic approach can induce a suitable change 
in the genetic profile of hASCs towards a cardiomyocytes-like lineage, without affecting 
their angiogenic capability.
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In Vivo Studies Using an Acute Myocardial Infarction Mice Model
As the final step of our investigation, we evaluated the therapeutic efficacy of pre-
conditioned hASCs in vivo in an immunodeficient AMI mice model. Our main hypothesis is 
that hASCs subjected to mechanical stimuli can significantly improve cardiac function when 
compared to hASCs cultured in a static environment. Specifically, the observed upregulation 
of cardiomyogenic markers, observed in vitro, should enhance the hASCs’ ability to act as 
competent myocytes in vivo leading to improved cardiovascular regeneration. To test this 
hypothesis, hASCs were cultured on the GelMA discs for 7 days in static and cyclic strain 
conditions as explained in the previous section. hASCs were then harvested from the GelMA 
discs and encapsulated in a Matrigel® hydrogel used as a carrier to deliver them into the 
injured myocardium of mice (Fig. 3a). We chose Matrigel® because it is a well-known 
biocompatible ECM-based matrix that has been widely used to deliver stem cell to the 
myocardium to ensure high viability, migration, and proliferation upon delivering.43
To assess the cardiac function, preliminary baseline echocardiographs (ECGs) were recorded 
for all the test groups and subsequently compared to ECGs collect at day 3 and 21. The two 
cardiac parameters obtained from the ECGs analysis were ejection fraction (EF%) and 
fractional shortening (FS%). The EF and FS are important systolic functional factors that are 
used to study the effect of AMI pathology on cardiac function. At day 3, no significant 
difference in cardiac function was found between the tested groups. However, on day 21 an 
increase in the two cardiac parameters was observed in the hASCs cyclic group (EF% 22.0 
± 2.6, FS% = 10.23 ± 1.28) with respect to the hASCs static group (EF% = 18.25 ± 1.12, FS
% = 8.35 ± 0.39) (Figs. 3b and 3c).
On the contrary, no improvement in cardiac output (CO%) and stroke volume (SV) was 
observed at day 21 in the two groups (Fig. S6). These results confirmed a modest 
improvement in heart function post-AMI induced by the injection of pre-conditioned 
hASCs.
Aside from assessing cardiac function, it was also important to verify whether our strategy 
could have a beneficial effect in reversing cardiac remodeling, which involves 
cardiomyocyte necrosis and consequent scar area formation. Specifically, upon myocardial 
infarction, fibrous scar tissue replaces functional myocardium causing the thinning of the 
left ventricle (LV) wall. This change in myocardial tissue is irreversible and can ultimately 
lead to heart failure.
Histological analysis of heart sections performed on the different groups revealed the 
expected LV wall thinning due to myocardial infarction. A slight reduction in the infarct size 
area was observed in the hASC cyclic group (35.2 ± 1.9%) with respect to hASC static 
group (39.1 ± 9.2%). However, this difference was not statistically significant likely due to 
the limited number of animals tested (n = 3) (Figs. 4a and 4b).
Finally, an effective therapy for cardiac repair post-AMI should also promote 
neovascularization in the peri-infarct region aside from reducing the scar area formation. To 
evaluate the angiogenic potential of preconditioned hASCs, mice were sacrificed, and 
excised hearts were stained for vWF and SMA within the periinfarct region (Fig. 4c) 
Chakravarti et al. Page 13













following established protocols.70 vWF staining is a useful strategy to detect the presence of 
endothelial cells which forms the inner lining of the lumen of blood vessels, while SMA 
protein is commonly found in vascular smooth muscle cells. A higher density of vWF and 
SMA positive blood vessels were detected in mice treated with hASC cyclic at day 21 
(14.33 ± 1.60) in comparison to hASC static (10.66 ± 1.15) (Fig. 4d). This positive 
angiogenic response associated with improved cardiac function determined by the 
assessment of systolic functional parameters indicate the ability of our strategy to enhance 
the therapeutic efficacy of hASCs to treat myocardial infarction.
CONCLUSION
We have successfully designed a biomimetic system that closely mimics the native 
mechanical stimulation generated by CMs. The cyclic strain provided by the rhythmic 
beating allowed for the modulation of the genetic profile of hASCs. Specifically, we found 
an upregulation of mechano-transduction genes such as YAP1 and TAZ, as well as 
overexpression of cardiomyogenic markers as observed in the metatranscriptomic analysis. 
These findings are indicative of a direct correlation between this mechanical stimulus and 
cardiomyogenic differentiation of hASCs. Furthermore, the designed biomimetic system did 
not hinder the inherent ability of hASCs to secrete proangiogenic factors, which is beneficial 
for myocardial tissue repair. Finally, upon transplantation of the preconditioned hASCs into 
AMI mice model, we observed an improvement in cardiac function and increased 
angiogenesis in the peri-infarct region after 21 days. Overall, these data indicate that cyclic 
strain is an effective stimulant for hASCs cardiomyogenic differentiation, and represents a 
promising approach to generate more efficient stem-cell based therapies for cardiovascular 
repair.
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Design and fabrication of the biomimetic system. (a) Schematic displays the overall design 
of the biomimetic system. hASCs were cultured on a thin GelMA disc placed on top of a 
layer of beating CMs. (b) Fluorescent confocal image of the 3D construct. Actin fibers of 
CMs were stained with Phalloidin tagged with Alexa Fluor 488 (Green) while the actin 
fibers of hASCs (top layer) were visualized using Alexa Fluor-594 (Red). Nuclei of both cell 
layers were stained using DAPI (blue). The middle section is represented by the GelMA 
disc. (c) Fluorescent images of the confluent monolayers of hASCs and CMs and the 
corresponding beating frequency graphs showing the displacement vs. time (sec). Scale bar 
= 100 μm (10× magnification). (d) Representative frequency sweeps test carried out at day 0 
and day 7 in the range of frequencies from 0.01 up to 10 Hz. G’ storage modulus and G” 
viscous moduli are reported with solid and hollow circles, respectively. No significant 
change in the G’ values of GelMA discs was observed at the two different time points. (e) 
Equilibrium of swelling of GelMA discs in PBS (pH 7.4) carried out over a period of 7 days. 
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The plateau was reached after 4 days. Data are reported as mean ± standard deviation (n = 
6).
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Activation of mechano-transduction genes, angiogenic and myogenic differentiation markers 
of hASCs post-exposure to cyclic strain stimuli. (a) qPCR analysis of the main mechano-
transduction genes including ACTA2, TAZ, YAP1, and CDC42 after 1 day of exposure to 
cyclic strain induced by beating cardiomyocytes. The static control group consisted of 
hASCs cultured on GelMA disc without exposure to any physical stimulation (n = 3). (b) 
Schematic represents the YAP1-TAZ signaling mechanotransduction pathway, which was 
activated in hASCs post mechanical stimulation. (c) Metatranscriptomics analysis of 
different angiogenic and myogenic differentiation markers in hASCs cultured on GelMA 
disc with and without cyclic strain. Genes are subdivided into two groups based on the 
different range of gene expression among the groups. Data are reported as mean ± standard 
deviation and normalized to day 1 gene expression derived from hASCs cultured in static 
condition. *p < 0.05, **p < 0.01, and ***p < 0.001.
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In Vivo assessment of cardiac function upon treatment with pre-conditioned hASCs. (a) 
Schematic showing the experimental design of the study. Four different groups were tested 
in an AMI mice immunodeficient model. Specifically, either PBS (sham control), Matrigel® 
(vehicle control), hASCs cultured in static conditions encapsulated in Matrigel® (hASC 
static) or hASCs pre-conditioned using the designed in vitro biomimetic system 
encapsulated in Matrigel® (hASC cyclic) were injected into the peri-infarct region of mice 
hearts 15 min post-infarction. (b) Calculated ejection fractions (EF%) at day 3 and day 21. A 
significant increase was observed in the cyclic strain group compared to the static group at 
day 21. (c) Assessment of fractional shortening (FS%) monitored at day 3 and day 21. An 
increase in this parameter was observed only in cyclic strain group at day 21. Data are 
expressed as mean ± standard deviation, *p < 0.05, **p < 0.01, and ***p < 0.001 (n = 4).
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Evaluation of the in vivo pro-angiogenic properties and myocardial remodeling after 
treatment with pre-conditioned hASCs. Four different groups were tested as reported 
previously. (a) Masson’s trichrome stain cross-sections of mice hearts are indicating the scar 
formation in each group stained in blue. (b) Quantification of the percentage of myocardium 
replaced by infarcted tissue detected in each group. The infarct size was calculated based on 
at least three different hearts in each group (n = 3). (c) Representative micrographs of 
immunohistochemically stained sections of the peri-infarcted regions showing the presence 
of endothelial cells (vWF) in red, mural cells (SMA) green. Scale bar = 50 μm. (d) 
Quantification of blood vessels density obtained from a minimum of six fluorescent images 
per group. A higher blood vessels density was observed in the mice hearts that were treated 
with the mechanically pre-conditioned hASCs group (hASC cyclic) at day 21. Data are 
expressed as mean mean ± standard deviation, *p < 0.05, **p < 0.01, and ***p < 0.001 (n = 
6).
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